Grant: Alliance Grants
McGill University
$64,295.00
Microbial consortia for enhanced and sustainable cannabis production
EF 2021-22
Résumé
The research described in this proposal will produce critical knowledge relevant for the cannabis industry, allowing for the production of high-quality plant material with optimum cannabinoid concentrations. The project will address three knowledge gaps regarding the use of microbial inoculants in cannabis production: 1) how a commercial microbial inoculant, Miicrobial Mass, affects plant growth parameters, flower yield and cannabinoid concentrations; 2) how the application of Miicrobial Mass alters cannabinoid accumulation through changes at the proteomic level; and 3) determine how cannabis root colonization by microbial inoculants depends on the growing medium and production system. This research is important because cannabis producers must be able to grow consistent plant material while reducing the financial and environmental costs associated with synthetic fertilizer inputs. Outcomes of this project could be improved crop production methods for cannabis producers to increase the legal cannabis supply in Canada, making it important for cannabis producers, clinicians who prescribe medical cannabis and patients that use medical cannabis. Cannabis producers will benefit from improved yield and reduced production costs; clinicians will benefit from a wider range of consistent cannabis products that can be evaluated in clinical trials for treatment of a variety of medical conditions; patients will benefit from improved access to a range of high-quality cannabis-based pharmaceutical products. The anticipated outcomes of this project are: an improved understanding of how microbial inoculants interact with cannabis plants to improve growth, yield and/or cannabinoid accumulation. This knowledge will pave the way for the development of further microbial-based products for use in cannabis production systems that cultivate plants in pots and hydroponic systems. Miicrobial Mass and Ulysse Biotech, the industrial partners, will benefit through improved knowledge of the mechanisms underlying the effects of their microbial inoculant product. Canada will benefit by using this knowledge to position itself as a world leader in production of high-quality cannabis, increased tax revenues from cannabis sales.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
557075-2020
Name nom
Smith, Donald
Department département
Plant Science
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2020
Award amount
64295
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1209
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Agriculture
Area of application fr
Agriculture
Research subject code
4900
Research subject group en
Plant and treebiology
Research subject group fr
Biologie végétale et des arbres
Research subject en
Plant and treebiology
Research subject fr
Biologie végétale et des arbres
Installment
inst:2
Partie
1
Nb partie
2
Application title
Microbial consortia for enhanced and sustainable cannabis production
Keyword
NSERC
Application summary
The research described in this proposal will produce critical knowledge relevant for the cannabis industry, allowing for the production of high-quality plant material with optimum cannabinoid concentrations. The project will address three knowledge gaps regarding the use of microbial inoculants in cannabis production: 1) how a commercial microbial inoculant, Miicrobial Mass, affects plant growth parameters, flower yield and cannabinoid concentrations; 2) how the application of Miicrobial Mass alters cannabinoid accumulation through changes at the proteomic level; and 3) determine how cannabis root colonization by microbial inoculants depends on the growing medium and production system. This research is important because cannabis producers must be able to grow consistent plant material while reducing the financial and environmental costs associated with synthetic fertilizer inputs. Outcomes of this project could be improved crop production methods for cannabis producers to increase the legal cannabis supply in Canada, making it important for cannabis producers, clinicians who prescribe medical cannabis and patients that use medical cannabis. Cannabis producers will benefit from improved yield and reduced production costs; clinicians will benefit from a wider range of consistent cannabis products that can be evaluated in clinical trials for treatment of a variety of medical conditions; patients will benefit from improved access to a range of high-quality cannabis-based pharmaceutical products. The anticipated outcomes of this project are: an improved understanding of how microbial inoculants interact with cannabis plants to improve growth, yield and/or cannabinoid accumulation. This knowledge will pave the way for the development of further microbial-based products for use in cannabis production systems that cultivate plants in pots and hydroponic systems. Miicrobial Mass and Ulysse Biotech, the industrial partners, will benefit through improved knowledge of the mechanisms underlying the effects of their microbial inoculant product. Canada will benefit by using this knowledge to position itself as a world leader in production of high-quality cannabis, increased tax revenues from cannabis sales.